FinTechFunding

Proteomics International: Raises $6M for high-tech blood test

  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Previous article
MRG Metals: Completes phase two drilling in Mozambique
Next article
PainChek: Signs partnership deal with disability service provider
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Truist Pilots Zelle Bill Payments, Strengthening Digital Banking Services

New pilot program aims to simplify bill payments through Zelle for customers.Highlights: Truist launches pilot program for Zelle...
FinTech

ACI Worldwide Strengthens Payment Solutions with Cloud-Native Platform

New platform enhances support for eight U.S. payment networks.Highlights: ACI Worldwide launches a cloud-native payment platform.The platform supports...
FinTech

LendingClub Rebrands as Happen Bank, Strengthens Digital Banking Services

The transformation aims to enhance customer engagement and streamline services.Highlights: LendingClub officially rebrands to Happen Bank.The rebrand focuses...
FinTech

NatWest Strengthens Venture Banking by Partnering with AWS

Collaboration will enhance digital services for startups and scale-ups.Highlights: NatWest partners with AWS to launch a new venture...